Abstract
Evidence-based public health approaches that minimize the introduction and spread of new SARS-CoV-2 transmission clusters are urgently needed in the United States and other countries struggling with expanding epidemics. Here we analyze 247 full-genome SARS-CoV-2 sequences from two nearby communities in Wisconsin, USA, and find surprisingly distinct patterns of viral spread. Dane County had the 12th known introduction of SARS-CoV-2 in the United States, but this did not lead to descendant community spread. Instead, the Dane County outbreak was seeded by multiple later introductions, followed by limited community spread. In contrast, relatively few introductions in Milwaukee County led to extensive community spread. We present evidence for reduced viral spread in both counties, and limited viral transmission between counties, following the statewide “Safer at Home” public health order, which went into effect 25 March 2020. Our results suggest that early containment efforts suppressed the spread of SARS-CoV-2 within Wisconsin.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project was funded in part through a COVID-19 Response grant from the Wisconsin Partnership Program at the University of Wisconsin School of Medicine and Public Health. KMB is supported by F30 AI145182-01A1 from the National Institutes of Allergy and Infectious Disease. GKM is supported by an NLM training grant to the Computation and Informatics in Biology and Medicine Training Program (NLM 5T15LM007359).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Waiver of HIPAA Authorization and approval to obtain the clinical samples along with a Limited Data Set was provided by the Western Institutional Review Board (WIRB #1-1290953-1).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Sequencing data after mapping to SARS-CoV-2 reference genome (Genbank: MN908947.3) have been deposited in the Sequence Read Archive (SRA) under bioproject PRJNA614504. Derived data, analysis pipelines, and figures have been made available for easy replication of these results at a publicly-accessible GitHub repository: https://github.com/gagekmoreno/SARS-CoV-2-in-Southern-Wisconsin.
All sequences have been uploaded to GISAID and GenBank. Associated accession numbers can be found in supplementary information 1 file.
https://github.com/gagekmoreno/SARS-CoV-2-in-Southern-Wisconsin
